Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rizwan Romee

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Clinical Transplantation|January 21, 2016
Graft-versus-host disease after liver transplantation: the effect of recipient-donor age differenceArmin Rashidi, Rizwan Romee
Cell Stem Cell|September 6, 2024
A one-way street recognition approach to mediate allogeneic immune cell therapiesFuguo Liu, Rizwan Romee
Stem Cell Research & Therapy|December 5, 2021
Cytokine-induced memory-like natural killer cells for cancer immunotherapyMubin Tarannum, Rizwan Romee
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 18, 2019
Inducing Fat to Feed a Natural Killer of MalignancyBenedetta Rambaldi, Rizwan Romee
Cell Reports. Medicine|March 4, 2022
Autologous cellular therapy for myeloma: Giving <i>ex vivo</i> expanded NK cells their dueRoman M Shapiro, Rizwan Romee
Current Hematologic Malignancy Reports|November 12, 2020
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and ChallengesJessica S Little, Rizwan Romee
Lancet (London, England)|January 11, 2025
iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphomaRoman M Shapiro, Rizwan Romee
Haematologica|August 28, 2015
ADAM17 and CD56low CD16low NK cellsRizwan Romee, Jeffrey S Miller
The New England Journal of Medicine|August 8, 2014
CMV prophylaxis in hematopoietic-cell transplantationRizwan Romee, John F DiPersio
Stem Cells Translational Medicine|December 24, 2023
Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based ImmunotherapyAndreia Maia, Mubin Tarannum, Rizwan Romee
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Clinical Transplantation|January 21, 2016
Graft-versus-host disease after liver transplantation: the effect of recipient-donor age differenceArmin Rashidi, Rizwan Romee
Cell Stem Cell|September 6, 2024
A one-way street recognition approach to mediate allogeneic immune cell therapiesFuguo Liu, Rizwan Romee
Stem Cell Research & Therapy|December 5, 2021
Cytokine-induced memory-like natural killer cells for cancer immunotherapyMubin Tarannum, Rizwan Romee
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 18, 2019
Inducing Fat to Feed a Natural Killer of MalignancyBenedetta Rambaldi, Rizwan Romee
Cell Reports. Medicine|March 4, 2022
Autologous cellular therapy for myeloma: Giving <i>ex vivo</i> expanded NK cells their dueRoman M Shapiro, Rizwan Romee
Current Hematologic Malignancy Reports|November 12, 2020
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and ChallengesJessica S Little, Rizwan Romee
Lancet (London, England)|January 11, 2025
iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphomaRoman M Shapiro, Rizwan Romee
Haematologica|August 28, 2015
ADAM17 and CD56low CD16low NK cellsRizwan Romee, Jeffrey S Miller
The New England Journal of Medicine|August 8, 2014
CMV prophylaxis in hematopoietic-cell transplantationRizwan Romee, John F DiPersio
Stem Cells Translational Medicine|December 24, 2023
Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based ImmunotherapyAndreia Maia, Mubin Tarannum, Rizwan Romee
Pageof 15